Molecular formula: | C22H22ClN5O2 |
Average mass: | 423.901 |
Monoisotopic mass: | 423.146203 |
ChemSpider ID: | 30922877 |
0 of 1 defined stereocentres
1260530-25-3
[RN]1260530-43-5
[RN]2-[6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide
[ACD/IUPAC Name]2-[6-(4-Chlorophényl)-8-méthoxy-1-méthyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazépin-4-yl]-N-éthylacétamide
[French]
[ACD/IUPAC Name]2-[6-(4-Chlorphenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamid
[German]
[ACD/IUPAC Name]4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-N-ethyl-8-methoxy-1-methyl-
[ACD/Index Name]6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide
molibresib
[INN] [USAN](S)-2-(6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-N-ethylacetamide
1260907-17-2
[RN]2-(6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-N-ethylacetamide
5QIO6SRZ2R
GSK 525762A
GSK 525768A
GSK-525762A(I-BET-762)
GSK2838232A
GSK525768A
GSK525768A;GSK-525768A
I-BET-762
I-BET762
MFCD22417091
[MDL number]Molibresib (I-BET-762)